The bowel and beyond: the enteric nervous system in neurological disorders

The enteric nervous system (ENS) is large, complex and uniquely able to orchestrate gastrointestinal behaviour independently of the central nervous system (CNS). An intact ENS is essential for life and ENS dysfunction is often linked to digestive disorders. The part the ENS plays in neurological disorders, as a portal or participant, has also become increasingly evident. ENS structure and neurochemistry resemble that of the CNS, therefore pathogenic mechanisms that give rise to CNS disorders might also lead to ENS dysfunction, and nerves that interconnect the ENS and CNS can be conduits for disease spread. We review evidence for ENS dysfunction in the aetiopathogenesis of autism spectrum disorder, amyotrophic lateral sclerosis, transmissible spongiform encephalopathies, Parkinson disease and Alzheimer disease. Animal models suggest that common pathophysiological mechanisms account for the frequency of gastrointestinal comorbidity in these conditions. Moreover, the neurotropic pathogen, varicella zoster virus (VZV), unexpectedly establishes latency in enteric and other autonomic neurons that do not innervate skin. VZV reactivation in these neurons produces no rash and is therefore a clandestine cause of gastrointestinal disease, meningitis and strokes. The gut–brain alliance has raised consciousness as a contributor to health, but a gut–brain axis that contributes to disease merits equal attention.

[1]  J. Jankovic Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  N. Halfon,et al.  What DSM-5 could mean to children with autism and their families. , 2013, JAMA pediatrics.

[3]  H. Braak,et al.  α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei , 2001, Acta Neuropathologica.

[4]  F. Jirik,et al.  Endogenous cellular prion protein regulates contractility of the mouse ileum , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  A. Chiò,et al.  Extensive genetics of ALS , 2012, Neurology.

[6]  S. Prusiner Biology and genetics of prions causing neurodegeneration. , 2013, Annual review of genetics.

[7]  D. Reis,et al.  Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum , 1981, Brain Research.

[8]  J. Atkin,et al.  Protein folding alterations in amyotrophic lateral sclerosis , 2016, Brain Research.

[9]  H. Laude,et al.  Endogenous prion protein conversion is required for prion‐induced neuritic alterations and neuronal death , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  R. Pfeiffer,et al.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation , 1995, The Lancet.

[11]  J. Furness The Enteric Nervous System , 2016, Advances in Experimental Medicine and Biology.

[12]  Robert Goodman,et al.  Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study∗ ∗ See accompanying Editorial, in this issue. , 2000, Biological Psychiatry.

[13]  Masam Yoshida [Varicella-zoster virus infection]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[14]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[15]  E. Tolosa,et al.  Alpha-synuclein immunoreactivity patterns in the enteric nervous system , 2015, Neuroscience Letters.

[16]  M. Gershon 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract , 2013, Current opinion in endocrinology, diabetes, and obesity.

[17]  C. Betancur,et al.  Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.

[18]  M. Levin Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  Jun Sun,et al.  Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model , 2015, Physiological reports.

[20]  M. Neunlist,et al.  Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System. , 2015, Journal of Parkinson's disease.

[21]  William W. Agace,et al.  Regional specialization within the intestinal immune system , 2014, Nature Reviews Immunology.

[22]  Hyun-Jung Cho,et al.  The enteric nervous system and gastrointestinal innervation: integrated local and central control. , 2014, Advances in experimental medicine and biology.

[23]  W. Poewe,et al.  Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model , 2010, Movement disorders : official journal of the Movement Disorder Society.

[24]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[25]  E. Gross,et al.  BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Neuronal Serotonin Regulates Growth of the Intestinal Mucosa in Mice , 2012 .

[26]  S. Mazmanian,et al.  Review Control of Brain Development, Function, and Behavior by the Microbiome Figure 2. Microbiome Influence on Bbb Integrity , 2022 .

[27]  J. Trojanowski,et al.  Expression patterns of β‐amyloid precursor protein (β‐APP) in neural and nonneural human tissues from alzheimer's disease and control subjects , 1991 .

[28]  S. McKeown,et al.  Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis. , 2016, Gene.

[29]  C. Carroll,et al.  Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease , 2014, Acta Neuropathologica.

[30]  G. Giannaccini,et al.  Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. , 2015, Central nervous system agents in medicinal chemistry.

[31]  M. Kiaei,et al.  Premature death of TDP‐43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis , 2013, International journal of experimental pathology.

[32]  Scott F. Hall,et al.  Enteric Dopaminergic Neurons: Definition, Developmental Lineage, and Effects of Extrinsic Denervation , 2003, The Journal of Neuroscience.

[33]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[34]  Jay Shendure,et al.  Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development , 2014, Cell.

[35]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.

[36]  Ling-Zhi Wang,et al.  Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.

[37]  C. C. Johnson,et al.  The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.

[38]  P. Tam,et al.  An immunohistochemical study of neuronal microtubule-associated proteins in Hirschsprung's disease. , 1993, Human Pathology.

[39]  J. Tapia,et al.  ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function , 2016, Nature Communications.

[40]  H. Reichmann,et al.  Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.

[41]  J. Bienenstock,et al.  Vagal pathways for microbiome-brain-gut axis communication. , 2014, Advances in experimental medicine and biology.

[42]  R. Heuckeroth,et al.  Building a second brain in the bowel. , 2015, The Journal of clinical investigation.

[43]  T. Powley,et al.  Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat , 2009, Experimental Neurology.

[44]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[45]  S. Hamilton-Dutoit,et al.  Pathological α‐synuclein in gastrointestinal tissues from prodromal Parkinson disease patients , 2016, Annals of neurology.

[46]  M. Gershon,et al.  Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice , 2006, The Journal of Neuroscience.

[47]  K. Tredici,et al.  Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases , 2011, Journal of the Neurological Sciences.

[48]  M. Neunlist,et al.  The digestive neuronal–glial–epithelial unit: a new actor in gut health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[49]  T. Powley,et al.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease? , 2008, Neuroscience.

[50]  C. Duncan,et al.  Varicella zoster virus immunity: A primer. , 2015, The Journal of infection.

[51]  S. Holland-Cunz,et al.  Acquired intestinal aganglionosis after a lytic infection with varicella-zoster virus. , 2006, Journal of pediatric surgery.

[52]  J. W. Aldren Turner,et al.  THE AUTONOMIC NERVOUS SYSTEM , 1955 .

[53]  W. Robberecht,et al.  Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice , 2014, Molecular Neurodegeneration.

[54]  L. Parkkinen,et al.  Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease , 2015, Neurology.

[55]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[56]  J. Neu,et al.  Tight junctions, leaky intestines, and pediatric diseases , 2005, Acta paediatrica.

[57]  P. Tam Hirschsprung's disease: A bridge for science and surgery. , 2016, Journal of pediatric surgery.

[58]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[59]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[60]  J. Sweatt,et al.  Pitt–Hopkins Mouse Model has Altered Particular Gastrointestinal Transits In Vivo , 2015, Autism research : official journal of the International Society for Autism Research.

[61]  Giovanni Di Guardo,et al.  Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine , 2008, Autonomic Neuroscience.

[62]  Subrata Ghosh Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease. , 2004, Advanced drug delivery reviews.

[63]  Hitoshi Takahashi,et al.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.

[64]  C. Adler,et al.  Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss , 2012, Acta Neuropathologica.

[65]  P. D'eufemia,et al.  Abnormal intestinal permeability in children with autism , 1996, Acta paediatrica.

[66]  F. Fornai,et al.  Parallel manifestations of neuropathologies in the enteric and central nervous systems , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[67]  E. Horváth-Puhó,et al.  Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.

[68]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[69]  W. Shankle,et al.  Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: enteric neurons in Alzheimer disease. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[70]  N. Weiner,et al.  Regulation of norepinephrine biosynthesis. , 1970, Annual review of pharmacology.

[71]  J. Furness,et al.  Anatomical evidence for ileal Peyer’s patches innervation by enteric nervous system: a potential route for prion neuroinvasion? , 2008, Cell and Tissue Research.

[72]  J. Eikenboom,et al.  Heparin-Induced Thrombocytopenia. , 2015, The New England journal of medicine.

[73]  C. Masters,et al.  Transmissible spongiform encephalopathies , 2004, The Lancet.

[74]  H. Braak,et al.  Pathoanatomy of Parkinson’s disease , 2000, Journal of Neurology.

[75]  C. Bern Chagas' Disease. , 2015, The New England journal of medicine.

[76]  K. Jellinger A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. , 2009, Biochimica et biophysica acta.

[77]  Mustafa M. Husain,et al.  Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.

[78]  R. Giorgio The Enteric Nervous System, J.B. Furness. Blackwell Publishing, Oxford (2006), (274 pp., Price GBP 55.00, ISBN 1-4051-3376-7) , 2006 .

[79]  John Q. Trojanowski,et al.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases , 2009, Journal of Neurology.

[80]  Jeremy Veenstra-VanderWeele,et al.  Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior , 2012, Proceedings of the National Academy of Sciences.

[81]  J. Sweatt,et al.  Pitt–Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription , 2013, Experimental & Molecular Medicine.

[82]  Mogens Vestergaard,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. , 2013, JAMA.

[83]  H. Reichmann,et al.  Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice , 2009 .

[84]  Udo Rüb,et al.  Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.

[85]  S. Gruber,et al.  Ogilvie syndrome and herpes zoster: case report and review of the literature. , 2010, The Journal of emergency medicine.

[86]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[87]  K. Sharkey,et al.  Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study , 2008, Journal of autism and developmental disorders.

[88]  J. Jankovic,et al.  The role of FUS gene variants in neurodegenerative diseases , 2014, Nature Reviews Neurology.

[89]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[90]  A. Posar,et al.  Autism according to diagnostic and statistical manual of mental disorders 5th edition: The need for further improvements , 2015, Journal of pediatric neurosciences.

[91]  J. Langston,et al.  Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits , 2012, Neurobiology of Disease.

[92]  N. Foster,et al.  Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system. , 2015, Journal of Alzheimer's disease : JAD.

[93]  K. Tieu,et al.  A guide to neurotoxic animal models of Parkinson's disease. , 2011, Cold Spring Harbor perspectives in medicine.

[94]  J. Trojanowski,et al.  Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. , 1991, Annals of neurology.

[95]  N. Cairns,et al.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.

[96]  K. Shannon,et al.  Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[97]  R. Knight,et al.  Gut Microbes and the Brain: Paradigm Shift in Neuroscience , 2014, The Journal of Neuroscience.

[98]  L. Davis,et al.  Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. , 2012, Transactions of the American Clinical and Climatological Association.

[99]  M. Sens,et al.  Amyloid Precursor Protein Expression Modulates Intestine Immune Phenotype , 2011, Journal of Neuroimmune Pharmacology.

[100]  S. B. des Varannes,et al.  Routine colonic biopsies as a new tool to study the enteric nervous system in living patients , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[101]  A. Aguzzi Unraveling prion strains with cell biology and organic chemistry , 2008, Proceedings of the National Academy of Sciences.

[102]  D. Munoz,et al.  Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[103]  R. Blakely,et al.  Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. , 2016, The Journal of clinical investigation.

[104]  T. Wyss-Coray,et al.  Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression. , 2013, Journal of Alzheimer's disease : JAD.

[105]  H. Clevers The Intestinal Crypt, A Prototype Stem Cell Compartment , 2013, Cell.

[106]  R. Nussbaum,et al.  Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. , 2010, Human molecular genetics.

[107]  D. Murphy,et al.  Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter , 1993, Journal of neurochemistry.

[108]  A Chakravarti,et al.  Hirschsprung disease, associated syndromes and genetics: a review , 2001, Journal of Medical Genetics.

[109]  V. Smith,et al.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism , 2014, Archives of Disease in Childhood: Education & Practice Edition.

[110]  Alan H Feiveson,et al.  Varicella-zoster virus in the saliva of patients with herpes zoster. , 2008, The Journal of infectious diseases.

[111]  R. Heuckeroth Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration. , 2015, The Journal of clinical investigation.

[112]  S. Chandra,et al.  Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis , 2014, The Journal of Neuroscience.

[113]  D. Selkoe,et al.  Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.

[114]  Bradley J. Ferguson,et al.  Brief Report: Whole Blood Serotonin Levels and Gastrointestinal Symptoms in Autism Spectrum Disorder , 2016, Journal of autism and developmental disorders.

[115]  M. Helwig,et al.  Caudo-rostral brain spreading of α-synuclein through vagal connections , 2013, EMBO molecular medicine.

[116]  M. Aschner,et al.  Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration Studies. , 2016, Chemical research in toxicology.

[117]  S. Chandra,et al.  Monomeric Synucleins Generate Membrane Curvature* , 2012, The Journal of Biological Chemistry.

[118]  M. Gershon,et al.  Use of Saliva to Identify Varicella Zoster Virus Infection of the Gut. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  H. Reichmann,et al.  Does vagotomy reduce the risk of Parkinson's disease? , 2015, Annals of neurology.

[120]  M. Chesselet,et al.  Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[121]  Carmela Bravaccio,et al.  Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives , 2010, Journal of pediatric gastroenterology and nutrition.

[122]  Thomas G. Schulze,et al.  Defining the Phenotype in Human Genetic Studies: Forward Genetics and Reverse Phenotyping , 2005, Human Heredity.

[123]  S. Prusiner,et al.  Prion Uptake in the Gut: Identification of the First Uptake and Replication Sites , 2011, PLoS pathogens.

[124]  L. Cote,et al.  Parkinson's disease and megacolon , 1987, Neurology.

[125]  李春岩 HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice , 2012 .

[126]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[127]  Crystal Davis,et al.  C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS , 2014, Brain Research.

[128]  K. Jellinger,et al.  The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease , 2008, Neuropathology and applied neurobiology.

[129]  M. Gershon Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. , 2012, Transactions of the American Clinical and Climatological Association.

[130]  Marta García-Fiñana,et al.  The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[131]  S. Qualman,et al.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia: Similarity to Parkinson's disease , 1984 .

[132]  K. Kawai,et al.  Annual incidence rates of herpes zoster among an immunocompetent population in the United States , 2015, BMC Infectious Diseases.

[133]  E. Masliah,et al.  Alzheimer's disease: recent advances and future perspectives. , 2012, Journal of Alzheimer's disease : JAD.

[134]  J. Homberg,et al.  Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[135]  J. Morrissey,et al.  The Absence of Tryptophan Hydroxylase Activity in Blood Platelets , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[136]  M. Gershon Developmental determinants of the independence and complexity of the enteric nervous system , 2010, Trends in Neurosciences.

[137]  Jane A Foster,et al.  In utero exposure to valproic acid and autism--a current review of clinical and animal studies. , 2013, Neurotoxicology and teratology.

[138]  A. Gitler,et al.  Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia , 2016, Journal of neurochemistry.

[139]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[140]  Reinhard Schliebs,et al.  Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling , 2005, Neurochemical Research.

[141]  Jia-Yi Li,et al.  Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.

[142]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[143]  S. Bischoff,et al.  Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[144]  S. Srinivasan,et al.  Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease , 2007, Experimental Neurology.

[145]  Hitoshi Takahashi,et al.  Tyrosine hydroxylase-immunoreactive intrinsic neurons in the Auerbach's and Meissner's plexuses of humans , 1989, Neuroscience Letters.

[146]  M. Chesselet,et al.  Abnormal colonic motility in mice overexpressing human wild-type &agr;-synuclein , 2008, Neuroreport.

[147]  J. Mallet,et al.  Serotonin has a key role in pathogenesis of experimental colitis. , 2009, Gastroenterology.

[148]  S. Karpen,et al.  Gastrointestinal Symptoms in Autism Spectrum Disorder: A Meta-analysis , 2014, Pediatrics.

[149]  P. Patterson,et al.  Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism , 2012, Brain, Behavior, and Immunity.

[150]  H. Reichmann,et al.  Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice , 2012, Scientific Reports.

[151]  D. Murphy,et al.  Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[152]  A. Kraneveld,et al.  Intestinal inflammation in a murine model of autism spectrum disorders , 2014, Brain, Behavior, and Immunity.

[153]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.